Citations

Clear

135 citation(s) found for "Shams, H".

Impella Versus VA‐ECMO in Cardiogenic Shock: An Updated Systematic Review and Meta‐Analysis With Exploratory Matched‐Cohort Analyses
Mohamed, Ahmed , Elnady, Mohamed, Kholeif, Zeyad, Awashra, Ameer , Elsobky, Mohamed Sobhy, Ibrahim, Amr Ahmed, Elfeky, Abdallah Osama, Shams, Mahmoud, Rashwan, Rana , Tahhan, Imad Samman , Elnashar, Mohab , Ayman, Ranem, Hassanin, Mazen, Elharty, Hisham, Hakim, Diaa, Tahhan, Imad , Awashra, Ameer , Elnady, Mohamed , Kholeif, Zeyad , Elsobky, Mohamed, Elfeky, Abdalla, Shams, Mahmoud M. , Rashwan, Rana , Hakim, Diaa

Mayo Clinic

Catheterization and Cardiovascular Interventions | May 12, 2026 | Volume: 108 | Issue: 2 | Pages: 301-313

10.1002/ccd.70658 | PMID 42115817 Get It

ABSTRACT Observational studies comparing Impella and venoarterial extracorporeal membrane oxygenation (VA‐ECMO) in cardiogenic shock have reported inconsistent findings. We performed an updated systematic review and meta‐analysis, with exploratory matched‐cohort analyses where directly reportable propensity score–matched event‐level data were available. We searched PubMed, Scopus, Web of Science, and the Cochrane Library from inception through March 2026 for observational studies comparing Impella versus VA‐ECMO in adult patients with cardiogenic shock. The primary outcome was in‐hospital mortality. Secondary outcomes included all‐cause mortality, ICU outcomes, access site bleeding requiring transfusion, peripheral vascular complications, renal outcomes, and stroke. Random‐effects models using restricted maximum likelihood were applied. Fifteen observational studies including 22,618 patients were analyzed. In the primary crude analysis, Impella was not associated with a statistically significant difference in in‐hospital mortality (RR 0.84, 95% CI 0.66−1.07; p = 0.15) with substantial heterogeneity ( I ² = 92.9%). However, leave‐one‐out analysis identified an influential registry study; its exclusion markedly reduced heterogeneity and favored Impella ( p < 0.01). In exploratory propensity score‐matched analysis, Impella was also associated with lower in‐hospital mortality (RR 0.69, 95% CI 0.56−0.85, p < 0.01). Thirty‐day and 6‐month all‐cause mortality were neutral, whereas 12‐month mortality modestly favored Impella ( p = 0.048). Sensitivity analyses similarly resolved heterogeneity and favored Impella for selected secondary outcomes, including 6‐month mortality, acute kidney injury, and ischemic stroke. ICU mortality was neutral, while ICU length of stay was shorter with Impella ( p = 0.01). Impella was also associated with lower access site bleeding requiring transfusion ( p < 0.01), peripheral vascular complications ( p < 0.01), and hemorrhagic stroke ( p < 0.01). In this updated meta‐analysis of observational studies, the primary crude analysis of in‐hospital mortality was neutral overall but highly heterogeneous, whereas sensitivity and exploratory matched‐cohort analyses showed a more consistent association favoring Impella. Impella was also associated with lower bleeding and vascular complications and shorter ICU length of stay, although several outcomes remained sensitive to study‐level influence. These findings should be interpreted cautiously given the observational design, predominance of serious risk of bias, and strong potential for confounding by indication.
Real-time AI integration for MR to detect artifacts and guide pulse sequence adaptations
Gudmundson, Aaron T. , Shams, Zahra , Gad, Abdelrahman , Wang, Shuyuan , Simičić, Dunja , Murali-Manohar, Saipavitra , Simegn, Gizeaddis Lamesgin , Özdemir, Ipek , Davies-Jenkins, Christopher W. , Song, Yulu , Yedavalli, Vivek , Demirel, Ömer Burak , Wang, Shuyuan , Simegn, Gizeaddis L , Yedavalli, Vivek S , Oeltzschner, Georg , Sulam, Jeremias , Ganji, Sandeep K , Edden, Richard A E , Murali‐Manohar, Saipavitra , Özdemir, İpek , Davies‐Jenkins, Christopher W. , Schär, Michael

Mayo Clinic

No container title available | May 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.05.04.722724 | PMID 42146385 Get It

Abstract This work presents a first-of-its-kind artificial intelligence (AI-)integrated MR pulse sequence that detects out-of-voxel (OOV) artifacts in real-time (within-TR) and responds prospectively by updating the crusher gradient scheme. Per Excitation Real-time Execution & Guided Responses with Integrated Neural-network Evaluation (PEREGRINE), allows for deployment of deep learning models and pulse sequence updates. In this study, PEREGRINE operated a time-domain (TD) and frequency-domain (FD) convolutional autoencoder that detect OOV artifacts. Scans without (AI-off) and with (AI-on) updates were collected from the medial prefrontal cortex of healthy volunteers using a MEGA-edited MRS experiment. The degree of OOV contamination (OOV Score) was quantified per transient based upon the prevalence of OOV signals in the TD and FD data. OOV Scores above a user-defined threshold triggered an update of the crusher gradient scheme, iterating through 48 permutations (6 axis transpositions × 8 polarity flips). Within each 2-second TR, PEREGRINE successfully provided single-transient OOV Scores and updated gradients accordingly. No difference was observed between the OOV Scores from the full (“Full” condition) AI-on and AI-off sessions due to the AI-on scan cycling over better and worse gradient permutations relative to the AI-off scan. However, the AI-on scan had significantly lower OOV Scores than the AI-off scan when selecting the transients where PEREGRINE persisted (“Dwell” condition) on a given gradient permutation. Ultimately, Fit Quality Number (FQN) from linear combination modeling improved significantly for the AI-on compared to the AI-off scan. PEREGRINE enabled an adaptive and AI-integrated sequence allowing for real-time evaluation and response to OOV artifacts, identifying gradient modifications that produced less OOV contamination. Graphical Abstract Graphical Abstract Summary PEREGRINE, Per Excitation Real-time Execution & Guided Responses with Integrated Neural-network Evaluation, allows for pulse sequence updates using on-scanner deployed neural networks. To demonstrate the utility, PEREGRINE was used to operate two neural networks (time/frequency domain), trained to detect out-of-voxel artifacts, during a MEGA-edited MRS experiment in the prefrontal cortex. When artifacts were detected, PEREGRINE updated the crusher gradients within the same TR. Real-time, adaptive, and AI-driven MR will provide a long-awaited solution for combatting artifacts and poor data quality. Graphical Abstract Figure
Migraine with comorbid fibromyalgia: psychological burden and impact on frequency and severity of migraine attacks
Hussein, Mona, Elgenidi, Anas, Merghany, Nahla, Ismaeel, Ahmed Yehia , Abdelghaffar, Mohamed, Yacoub, Osama, Fayez, May M., Taha, Nourhan Abdelmohsen, Moustafa, Ramez Reda, Essmat, Ahmed, Hussein, Mona , Hussein, Mona , Hassan, Amr , Magdy, Rehab , Merghany, Nahla, Abdelghaffar, Mohamed, Essmat, Ahmed

Mayo Clinic

Frontiers in Neurology | April 30, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.3389/fneur.2026.1776543 | PMID 42147852 Get It

Background There is growing evidence suggesting a bidirectional relationship between fibromyalgia and migraine. The aim of this work was to study the impact of fibromyalgia on the frequency and severity of migraine headache attacks and the psychological burden in patients with comorbid migraine and fibromyalgia. Methods This cross-sectional comparative study was conducted on 114 patients with comorbid migraine and fibromyalgia and 270 patients with migraine only. All included patients were subjected to a comprehensive assessment of headache through face-to-face interview and assessment of the psychological state using the Depression, Anxiety and Stress Scale-12 (DASS-12). Patients with fibromyalgia were requested to answer the Revised Fibromyalgia Impact Questionnaire (FIQR). Results Patients with comorbid migraine and fibromyalgia had significantly higher monthly migraine days (MMD), headache impact test-6 (HIT-6), and DASS-12 total scores than patients with migraine only ( p -value &lt; 0.001, 0.009, and &lt; 0.001, respectively). There was a statistically significant positive correlation between the FIQR total score and DASS-12 total score ( p -values = 0.001). Additionally, statistically significant positive correlations were found between the FIQR total score and both the MMD and HIT-6 total scores ( p -values = 0.002 and 0.008, respectively). There were also statistically significant positive correlations between the DASS-12 total score and both the MMD and HIT-6 total scores ( p -values = 0.006, 0.027, respectively). Conclusion Fibromyalgia is an aggravating comorbid condition with migraine that is associated with a higher frequency and severity of migraine headache attacks, in addition to increasing the psychological burden.
Micro- and Nanoplastics Exposure and Effects on Embryonic Development and Larval Behavior of Zebrafish
Savage, Kaila S., Harris, Tiara Fryer, Itomura, Luke, Liang, Corina, Mak, Keala, Oglesby, Zachary, Ooi, Vincent, Quiroz, Gemma, Withy, Kelley , Pierret, Chris , Shams, Soaleha , Ooi, Vincent

Mayo Clinic

Zebrafish | April 9, 2026 | Volume: 23 | Issue: 2-3 | Pages: 53-63

10.1177/15458547261441746 | PMID 41951562 Get It

Hawai‘i and other island communities around the globe are experiencing high exposures to micro- and nanoplastics (MNPs). Widespread use of various types of plastics and the action of wave physics coupled with abundant silica creates a constant production of MNPs. The community health effects of exposure to MNPs are not yet fully understood. The aquatic vertebrate model zebrafish, Danio rerio , was utilized to evaluate the developmental and behavioral effects of nanoplastic (NP) exposure as well as visual confirmation of plastic accumulation after embryonic and larval exposure. Eye and yolk size, heart rate, angle of development, and early larval locomotion behavior were quantified after early NP exposure lasting 3 or 5 days. In this work, a digital laboratory environment is used as the context for research trainees spanning high school to graduate and medical school in Hawai‘i to explore health outcomes of developmental NP exposures. Presence of MNPs in the early developmental environment led to changes in growth and behavior of exposed fish. Data analysis showed significant effects of exposures on changes in the rate of development and yolk consumption on day 2 and reduced body length and increased locomotion on day 6. Nanoplastic exposure also affected overall body length, but this effect was not significant. These data support the potential dangers of MNP exposure and demonstrate their persistent detrimental effects on development and behavior in young zebrafish. Accordingly, our work contributes toward shifting focus toward understanding longer impacts on health, growth, and behaviors and potentially the reduction of harm in developing vertebrates.
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis and Prior Mediastinal Radiation: A Meta-Analysis of Short-Term and 1-Year Outcomes
Elbenawi, Hossam , Mostafa, N., Dahik, Buseyna, Botros, Michael, Eisa, Mahmoud , Zreigh, Sofian , Kalaiger, Abdul M., Almaadawy, Omar , Youssef, Mohammed, Zaaya, Morad, Stephens, R. E., Ghanim, Mostafa, Lin, Chien‐Jung, Elgendy, I S L A M, Goldsweig, Andrew M., Mostafa, Naydeen , Stephens, Richard, Kalaiger, Abdul Mukhtadir , Abdelgalil, Mahmoud Shaaban , Hamed, Belal Mohamed , Botros, Michael, Stephens, Richard, Elgendy, Islam Y. , Goldsweig, Andrew M.

Mayo Clinic

Cardiology in Review | March 31, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/crd.0000000000001263 | PMID 41913240 Get It

Mediastinal radiation potentiates aortic stenosis and complicates its treatment. We compared the short and midterm-outcomes with transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with prior mediastinal radiation. Electronic databases were searched from inception through December 2024. Dichotomous outcomes were pooled as risk ratios (RRs), and continuous outcomes were pooled as mean differences (MDs) with respective 95% confidence intervals (CIs). Six observational studies were identified, including 2458 TAVR patients and 1873 SAVR patients. In the short-term, TAVR was associated with lower rate of mortality (RR: 0.54; 95% CI: 0.34–0.88), atrial fibrillation (RR: 0.31; 95% CI: 0.15–0.65), acute kidney injury (RR: 0.75; 95% CI: 0.59–0.95), bleeding (RR: 0.37, 95% CI: 0.33–0.42), and shorter length of hospital stay (MD: −4.30; 95% CI: −5.45 to −3.15). One-year mortality was comparable between the 2 groups (RR: 1.04; 95% CI: 0.50–2.13). This meta-analysis of observational studies of patients with prior mediastinal radiation demonstrated that TAVR was associated with better short-term outcomes compared to SAVR. While 1-year mortality appeared similar between the 2 interventions, this finding should be interpreted with caution. However, randomized controlled trials are needed to validate these findings.
Efficacy, Safety, and Net Clinical Benefit of Post‐Atrial Fibrillation Ablation Anticoagulation
Abomohsen, Mustafa , Mohamed, Ahmed , Almakadma, Abdul Hakim , Mojahedi, Azad , Kholeif, Zeyad , Elalfy, A E, Shams, Mahmoud M. , Gadelmawla, Ahmed Farid , Tahhan, Imad Samman , Elnashar, Mohab, Rashwan, Rana , Elnady, Mohamed , Gunsburg, Moshe, Gadelmawla, Ahmed Farid , Mohamed, Ahmed Elmorsy , Tahhan, Imad , Elalfy, Aya, Elnashar, Mohab

Mayo Clinic

Pacing and Clinical Electrophysiology | March 27, 2026 | Volume: 49 | Issue: 5 | Pages: 590-601

10.1111/pace.70224 | PMID 41889075 Get It

ABSTRACT Background The optimal long‐term antithrombotic strategy after apparently successful catheter ablation of atrial fibrillation (AF) remains uncertain, particularly in patients who meet conventional guideline thresholds for oral anticoagulation (OAC). Objectives To compare continuation versus cessation strategies of long‐term OAC after successful AF ablation and to quantify net clinical benefit (NCB) integrating thromboembolic and bleeding outcomes. Methods We searched PubMed, Cochrane CENTRAL, and Embase from inception through February 2026 for randomized and comparative observational studies evaluating long‐term OAC continuation versus cessation (no OAC and/or switch to aspirin) after successful AF ablation. Risk of bias was assessed using RoB2 for randomized trials and a modified Newcastle–Ottawa Scale (NOS) for observational studies. Random‐effects meta‐analyses used a restricted maximum likelihood estimator with Hartung–Knapp adjustment. NCB was calculated as: thromboembolic event rate − (1.5 × major bleeding rate). Results Six studies met the inclusion criteria (four randomized trials and two observational cohorts). Stroke/transient ischemic attack (TIA) events were reported in six studies and were not significantly different between OAC continuation and cessation strategies (OR 0.69; 95% CI 0.24–1.99; p = 0.49). Systemic embolism (three studies) did not differ between groups ( p = 0.12). Major bleeding (five studies) was numerically higher with continued OAC but not statistically significant (OR 2.07; 95% CI 0.88–4.86; p = 0.09). In NCB analysis, continued OAC yielded more negative or near‐neutral NCB values, whereas, the cessation strategies were less negative or marginally positive; the fixed‐effect risk difference in NCB (continued OAC vs cessation) was +0.00067 (95% CI −0.00279 to +0.00413). Conclusion This meta‐analysis suggests that after successful AF ablation, continuing OAC does not significantly reduce stroke risk compared to cessation or switching to aspirin, but it may increase major bleeding. While NCB trends favor cessation, the low absolute event rates and the risk of silent AF recurrence necessitate caution.
Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression
Michels, Sebastian, Chen, Chaorong, Ruf, Wolfgang P., Garcia, M. Madhy Garcia, Arnold, Frederick J. , Wu, Zhuoxing, Shams, Daniel, Thompson, Leslie M., Walker, Alyssa C. , Petrucelli, Leonard, Dorst, Johannes, Li, Wei, Spada, Albert R. La, Dickson, Dennis W , Li, Wei , Michels, Sebastian , Chen, Chaorong, Ruf, Wolfgang Philipp , Bennett, Craig L. , Thompson, Leslie Michels , Dickson, Dennis W. , Petrucelli, Leonard , Dorst, Johannes , Prudencio, Mercedes , Li, Wei, Spada, Albert R. La

Mayo Clinic

No container title available | March 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.20.711195 | PMID 41928938 Get It

Abstract The role of the epigenome in age-related neurodegenerative disorders remains understudied. Here, we analyzed circulating cell-free DNA (cfDNA) from blood to detect methylation changes as a liquid-biopsy for Amyotrophic Lateral Sclerosis (ALS). Our study included 20 patients with sporadic ALS, 10 patients with C9orf72-associated ALS, 10 asymptomatic carriers of the C9orf72 repeat expansion mutation, and 21 non-disease controls. Following targeted enzymatic methyl-sequencing (EM-seq) of ∼4 million CpG sites, we detected numerous differentially methylated genes, including several implicated in ALS disease risk and pathogenesis. By integrating multiple epigenetic features, we delineated a distinct epigenetic signature, which achieved an average area under the curve (AUC) of 0.91 ± 0.10 upon receiver operator characteristic (ROC) analysis, which enabled detection of ∼70% of ALS patients with close to 100% specificity. Furthermore, we also identified a set of genes whose methylation status significantly correlated with clinical disease progression and cerebrospinal fluid (CSF) neurofilament levels. Our results reveal the potential of cfDNA-based biomarkers to accurately diagnose ALS and potentially predict disease progression.
International Dermoscopy Society consensus recommendations for the management of lentigo maligna
Forsea, Ana‐Maria , Akay, Bengü Nisa , Argenziano, Giuseppe, Briatico, Giulia , Cabo, Horacio , Cabrera, Raul, Carrera, C., Cinotti, Elisa, Conforti, Claudio, Errichetti, Enzo , Ferrara, Gerardo, Guida, Stefania, Guitera, Pascale, Heyes, Stephen J., Hofmann‐Wellenhof, R, Hong, A., Jaimes, Natalia , Karls, Raimonds, Kittler, Harald, Kränke, Teresa, Malvehy, Josep, Marghoob, Ashfaq A., Moneib, Hoda, Ramirez, David Moreno, Navarrete‐Dechent, Cristian, Pellacani, Giovanni, Peris, Ketty, Puig, S, Rudnicka, Lidia, Sadek, Ahmed, Saiag, Philippe, Soyer, Hans Peter, Starace, Michela V., Stolz, Wilhelm, Swanson, David C. , Thomas, Luc, Zalaudek, Iris, Lallas, Aimilios, Akay, Bengu Nisa , Apalla, Zoe , Argenziano, Giuseppe , Briatico, Giulia , Carrera, Cristina , Conforti, Claudio , Halpern, Allan C , Kränke, Teresa , Liopyris, Konstantinos , Liu, Jie , Moscarella, Elvira , Nagore, Eduardo , Navarrete-Dechent, Cristian , Paoli, John , Pellacani, Giovanni , Peris, Ketty , Puig, Susana , Rudnicka, Lidia , Scope, Alon , Starace, Michela V , Swanson, David L, Thomas, Luc , Tschandl, Philipp , Lallas, Aimilios , Pampena, Riccardo , Braun, Ralph Peter , Cabrera, Raúl , Cinotti, Élisa , Ferrara, Gerardo , Giuffrida, Roberta , Guida, Stefania , Guitera, Pascale , Heyes, Stephen, Karls, Raimonds, Kittler, Harald , Kränke, Teresa, Longo, Caterina , Malvehy, Josep , Marghoob, Ashfaq A. , Navarrete‐Dechent, Cristián , Peris, Ketty , Puig, Susana , Rosendahl, Cliff O. , Saïag, Philippe , Salerni, Gabriel , Scope, Alon , Soyer, H. Peter , Stolz, Wilhelm , Zalaudek, Iris

Mayo Clinic

Journal of the European Academy of Dermatology and Venereology | March 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/jdv.70406 | PMID 41854120 Get It

Abstract Lentigo maligna (LM) is a subtype of cutaneous melanoma in situ that develops on chronically sun‐damaged skin in elderly individuals. Its diagnosis and management remain challenging due to its slow progression, frequent occurrence on cosmetically sensitive areas in frail individuals, and tendency for subclinical peripheral extension. Despite its potential for invasive transformation, the natural history of LM remains incompletely understood and evidence‐based management strategies for this specific entity remain limited. This work aims to bridge the gap between scarce high‐quality evidence and the clinicians' need for practical guidance on LM management by formulating evidence‐based and expert consensus‐driven recommendations for diagnosis, treatment and follow‐up. Under the coordination of the International Dermoscopy Society, a global, multidisciplinary consortium of 53 experts—including dermatologists, dermato‐oncologists, dermatologic surgeons, radiologists, radiotherapists, pathologists and epidemiologists—formulated recommendations through structured consensus, informed by a comprehensive review of current scientific evidence and clinical practice standards. Optimal management of LM requires accurate diagnosis and individualized treatment planning. Non‐invasive skin imaging techniques, especially dermoscopy and reflectance confocal microscopy, aid in diagnosis, biopsy orientation, lesion delineation and post‐treatment monitoring. Multiple partial biopsies help confirm diagnosis and rule out invasion. Complete surgical excision remains the first treatment option. No definitive safety margins can be recommended for standard surgery; margin‐controlled techniques are preferable for large or ill‐defined lesions. Topical imiquimod and radiotherapy are effective alternatives where surgery is unsuitable. Topical imiquimod is useful as primary, adjuvant or neoadjuvant therapy. Blind destructive methods should be avoided. Close clinical and imaging follow‐up is needed. Patient‐centred care, shared decision‐making, and a multidisciplinary approach are critical for optimal outcomes. These international consensus recommendations summarize current best practices for LM management, offering practical, evidence‐informed guidance to clinicians while acknowledging the potential of future research in refining these conclusions.
Optimization, thermo-oxidative stability, and biological activities of vitamin E-chitosan–TPP nanoformulations
Ali, Hussein M. , Attia, Mohamed H. , Mamdouh, Wael , Rashed, Eman N., Ali, Isra H. , Mamdouh, Wael

Mayo Clinic

RSC Advances | January 26, 2026 | Volume: 16 | Issue: 6 | Pages: 5410-5426

10.1039/d5ra06012e | PMID 41602175 Get It

Enhancing stability is a crucial factor in selecting bioactive compounds in most applications, while encapsulation techniques have proven to be a promising solution.
Induction Regimens and Kidney Re‐Transplant Outcomes after BK Nephropathy–Related Graft Loss: A U.S. Cohort Study
El‐Rifai, Rasha , Fontana, Lauren, Jackson, Scott M. , Smith, Byron H. , Shams, Amir Hossein , Quintiliano, Artur, Bentall, Andrew , Razonable, Raymund R., Kandaswamy, Raja, Riad, Samy M. , Riad, Samy , Fontana, Lauren , Bentall, Andrew , Smith, Byron , Jackson, Scott, Razonable, Raymund R. , Kandaswamy, Raja

Mayo Clinic

Clinical Transplantation | January 9, 2026 | Volume: 40 | Issue: 1 | Pages: No page available

10.1111/ctr.70446 | PMID 41508800 Get It

ABSTRACT This study investigated the association between induction type and long‐term outcomes in kidney retransplant recipients who experienced graft loss due to BK virus–associated nephropathy (BKVAN). Using Scientific Registry of Transplant Recipients data (2003–2021), we identified 277 adult kidney‐alone retransplant recipients with BKVAN‐related graft loss and categorized them by induction regimen: depletional ( n = 217) and nondepletional ( n = 60). The groups were similar overall, except the nondepletional cohort had lower panel‐reactive antibodies, a shorter time between transplants, and more live donor kidneys. Kaplan–Meier curves assessed 10‐year recipient and graft survival, and Cox proportional hazards models, adjusted for key donor and recipient factors, evaluated associations between induction type and outcomes. Rates of delayed graft function, one‐year rejection, and estimated glomerular filtration rate were comparable between groups. Ten‐year recipient and death‐censored graft survival did not differ by induction type (recipient survival: HR 1.09; 95% CI 0.43–2.77; p = 0.85; graft survival: HR 0.85; 95% CI 0.24–2.97; p = 0.79). Recurrent BKVAN‐related graft failure occurred only in the depletional group (5 of 217; 2.3%), while rejection‐related graft failure was more common in the nondepletional group (5 of 60; 8.3% vs. 6 of 217; 2.8%). Although these differences did not translate into long‐term graft survival disparities, they highlight the competing risks of viral recurrence and rejection. Thus, clinicians should interpret these results with caution and weigh the risks and benefits of induction choice in retransplant recipients with prior BKVAN, recognizing that this observational study cannot establish causality.